Journal
JOURNAL OF PHARMACOLOGICAL SCIENCES
Volume 100, Issue 5, Pages 471-486Publisher
JAPANESE PHARMACOLOGICAL SOC
DOI: 10.1254/jphs.CR0050020
Keywords
gabapentin; GABA(B) receptor; NMDA receptor; K-ATP channel; alpha(2)delta subunit of Ca2+ channels
Categories
Ask authors/readers for more resources
Gabapentin, a gamma-aminobutyric acid (GABA) analogue anticonvulsant, is also an effective analgesic agent in neuropathic and inflammatory, but not acute, pain systemically and intrathecally. Other clinical indications such as anxiety, bipolar disorder, and hot flashes have also been proposed. Since gabapentin was developed, several hypotheses had been proposed for its action mechanisms. They include selectively activating the heterodimeric GABA(B) receptors consisting of GABA(B1a) and GABA(B2) subunits, selectively enhancing the NMDA current at GABAergic interneurons, or blocking AMPA-receptor-mediated transmission in the spinal cord, binding to the L-alpha-amino acid transporter, activating ATP-sensitive K+ channels, activating hyperpolarization-activated cation channels, and modulating Ca2+ current by selectively binding to the specific binding site of [H-3]gabapentin, the alpha(2)delta subunit of voltage-dependent Ca2+ channels. Different mechanisms might be involved in different therapeutic actions of gabapentin. In this review, we summarized the recent progress in the findings proposed for the antinociceptive action mechanisms of gabapentin and suggest that the alpha(2)delta subunit of spinal N-type Ca2+ channels is very likely the analgesic action target of gabapentin.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available